Literature DB >> 26086186

Short Communication: Virion Aggregation by Neutralizing and Nonneutralizing Antibodies to the HIV-1 Envelope Glycoprotein.

Marina R Alexander1, Rogier W Sanders1,2, John P Moore1, Per Johan Klasse1.   

Abstract

We used dynamic light scattering to detect aggregation of HIV-1 virions by antibodies (IgG) to the viral envelope glycoprotein (Env). Virions of different strains were inactivated by 2,2'-dithiodipyridine (AT-2), a procedure that abrogates infectivity but preserves the native antigenic structure of Env. Neutralizing antibodies directed to a V3-base- and glycan-dependent epitope on gp120 and to the apex of the Env trimer, as well as nonneutralizing antibodies to the epitope cluster I on the gp41-ectodomain, aggregated virions, but in markedly narrow concentration ranges. In contrast, the neutralizing antibody 2G12, which is specific for a composite glycan-dependent epitope on gp120 and functionally monovalent because of its unusual domain-swap structure, was nonaggregating. These results have potentially complex implications for vaccine development.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26086186      PMCID: PMC4651053          DOI: 10.1089/AID.2015.0050

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  47 in total

1.  Inhibition of rhinovirus attachment by neutralizing monoclonal antibodies and their Fab fragments.

Authors:  R J Colonno; P L Callahan; D M Leippe; R R Rueckert; J E Tomassini
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

2.  Relationship between poliovirus neutralization and aggregation.

Authors:  A A Thomas; R Vrijsen; A Boeyé
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

3.  The role of mononuclear phagocytes in HTLV-III/LAV infection.

Authors:  S Gartner; P Markovits; D M Markovitz; M H Kaplan; R C Gallo; M Popovic
Journal:  Science       Date:  1986-07-11       Impact factor: 47.728

4.  Neutralization of poliovirus by polyclonal antibodies requires binding of a single IgG molecule per virion.

Authors:  K Wetz; P Willingmann; H Zeichhardt; K O Habermehl
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

5.  Neutralization of poliovirus by antibody-mediated polymerization.

Authors:  P Brioen; D Dekegel; A Boeyé
Journal:  Virology       Date:  1983-06       Impact factor: 3.616

6.  Independent evolution of Fc- and Fab-mediated HIV-1-specific antiviral antibody activity following acute infection.

Authors:  Anne-Sophie Dugast; Leonidas Stamatatos; Andrew Tonelli; Todd J Suscovich; Anna F Licht; Iliyana Mikell; Margaret E Ackerman; Hendrik Streeck; P J Klasse; John P Moore; Galit Alter
Journal:  Eur J Immunol       Date:  2014-08-11       Impact factor: 5.532

7.  Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9.

Authors:  Jean-Philippe Julien; Jeong Hyun Lee; Albert Cupo; Charles D Murin; Ronald Derking; Simon Hoffenberg; Michael J Caulfield; C Richter King; Andre J Marozsan; Per Johan Klasse; Rogier W Sanders; John P Moore; Ian A Wilson; Andrew B Ward
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-20       Impact factor: 11.205

8.  Quantitative model of antibody- and soluble CD4-mediated neutralization of primary isolates and T-cell line-adapted strains of human immunodeficiency virus type 1.

Authors:  P J Klasse; J P Moore
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

Review 9.  Tetraspanins in extracellular vesicle formation and function.

Authors:  Zoraida Andreu; María Yáñez-Mó
Journal:  Front Immunol       Date:  2014-09-16       Impact factor: 7.561

10.  Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits.

Authors:  Anila Yasmeen; Rajesh Ringe; Ronald Derking; Albert Cupo; Jean-Philippe Julien; Dennis R Burton; Andrew B Ward; Ian A Wilson; Rogier W Sanders; John P Moore; Per Johan Klasse
Journal:  Retrovirology       Date:  2014-05-29       Impact factor: 4.602

View more
  5 in total

1.  A rapid ultrasound particle agglutination method for HIV antibody detection: Comparison with conventional rapid HIV tests.

Authors:  Simon Bystryak; Natalya Ossina
Journal:  J Virol Methods       Date:  2017-08-24       Impact factor: 2.014

Review 2.  How to assess the binding strength of antibodies elicited by vaccination against HIV and other viruses.

Authors:  P J Klasse
Journal:  Expert Rev Vaccines       Date:  2016-01-06       Impact factor: 5.217

Review 3.  Non-Neutralizing Antibodies Directed against HIV and Their Functions.

Authors:  Luzia M Mayr; Bin Su; Christiane Moog
Journal:  Front Immunol       Date:  2017-11-20       Impact factor: 7.561

Review 4.  Vaccine-induced V1V2-specific antibodies control and or protect against infection with HIV, SIV and SHIV.

Authors:  Susan Zolla-Pazner; Raymond Alvarez; Xiang-Peng Kong; Svenja Weiss
Journal:  Curr Opin HIV AIDS       Date:  2019-07       Impact factor: 4.283

Review 5.  Update on Fc-Mediated Antibody Functions Against HIV-1 Beyond Neutralization.

Authors:  Bin Su; Stefania Dispinseri; Valeria Iannone; Tong Zhang; Hao Wu; Raphael Carapito; Seiamak Bahram; Gabriella Scarlatti; Christiane Moog
Journal:  Front Immunol       Date:  2019-12-18       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.